Atrial Flutter, Multifocal Atrial Tachycardia & Premature Beats
Sawtooth at 150, three P waves in sick lungs, and when extra beats matter
Atrial flutter: mechanism and recognition
One big loop. Typical atrial flutter is a macroreentrant circuit that spins counterclockwise around the tricuspid annulus in the right atrium, passing through the cavotricuspid isthmus. The atria fire at about 250–350 bpm (classically 300). Flutter occurs with structural heart disease, COPD, recent cardiac surgery, and preexisting atrial fibrillation.
ECG. Negative sawtooth F waves in II, III, and aVF (positive in V1), with no flat baseline between them. The AV node cannot conduct every impulse, so the ventricular rate depends on the block ratio:
A regular rate of 150 is flutter until proven otherwise. With 2:1 block, every other F wave hides inside the QRS or T wave, so the rhythm is easily mistaken for sinus tachycardia or another SVT. Vagal maneuvers (such as carotid sinus massage) or IV adenosine during continuous ECG recording briefly deepen AV block and unmask the sawtooth. This diagnoses flutter without ending it, because the circuit lies entirely in the atrium. Variable block makes the ventricular rhythm irregular.
Class IC drugs (flecainide, propafenone) can slow the flutter circuit to about 200 bpm, slow enough for the AV node to conduct 1:1. The result is a very fast, wide-complex rhythm, so a class IC drug is always paired with an AV-nodal blocker (β-blocker, diltiazem, or verapamil).
Managing atrial flutter
- Unstable (hypotension, ischemia, shock, acute heart failure)Synchronized cardioversion. Flutter converts at low energy, often 50–100 J or less.
- Stable: rate or rhythmRate control with β-blockers, diltiazem or verapamil, or digoxin is harder than in AF, because the rate jumps between fixed ratios (150 → 75) instead of slowing smoothly. Rhythm control (cardioversion, ibutilide, dofetilide, ablation) is often preferred.
- Anticoagulate as for AFDecide by CHA2DS2-VASc and follow the pericardioversion rules.
- Recurrent or symptomatic typical flutterCavotricuspid isthmus (CTI) ablation.
Stroke prevention. Stroke risk in flutter resembles AF, so the same rules apply. Using CHA2DS2-VASc (heart failure, hypertension, age ≥75 [2 points], diabetes, prior stroke or TIA [2 points], vascular disease, age 65–74, female sex), anticoagulate at a score of ≥2 in men or ≥3 in women and consider it at 1 in men or 2 in women. A DOAC is preferred over warfarin unless there is a mechanical valve or moderate-to-severe mitral stenosis.
Cardioversion. For flutter lasting 48 hours or more, or of unknown duration, either give 3 weeks of anticoagulation first or do a TEE to exclude atrial thrombus, then continue anticoagulation for at least 4 weeks afterward. Rapid atrial overdrive pacing, for example through epicardial wires after cardiac surgery, can also terminate typical flutter.
CTI ablation. A linear lesion across the cavotricuspid isthmus interrupts the circuit with more than 90% success. It is first-line for recurrent or symptomatic typical flutter and is often preferred over long-term antiarrhythmic drugs such as amiodarone. Many patients develop AF later, so stroke-risk assessment continues after ablation.
Multifocal atrial tachycardia
Definition. An irregularly irregular rhythm above 100 bpm with at least three distinct P-wave morphologies in one lead, varying PR and P–P intervals, and an isoelectric baseline between P waves. It mimics AF, but discrete P waves are visible. Below 100 bpm the same pattern is called wandering atrial pacemaker.
Who gets it. Older, acutely ill patients: COPD exacerbation, hypoxemia or hypercapnia, pneumonia, pulmonary embolism, heart failure, or sepsis. Theophylline toxicity, β-agonists, hypomagnesemia, and hypokalemia increase atrial automaticity; check the theophylline level in a patient who takes it.
Treat the lungs, not the rhythm. Correct hypoxemia and treat the exacerbation, stop theophylline, and give IV magnesium (helpful even when the level is normal) and potassium. If the rate stays fast, use verapamil or diltiazem, or a β1-selective blocker if there is no bronchospasm; nonselective propranolol can worsen COPD. Cardioversion, antiarrhythmics, digoxin, and adenosine are ineffective, and MAT itself needs no anticoagulation.
Cardioversion fails in MAT because the rhythm comes from several automatic atrial foci, not a single reentrant circuit that a shock can reset.
| Feature | Typical flutter | MAT | Atrial fibrillation |
|---|---|---|---|
| Mechanism | Single right-atrial reentry loop | Multiple automatic atrial foci | Chaotic atrial activity |
| Atrial activity | Sawtooth F waves, ~300 bpm | ≥3 distinct P waves, varying PR | No organized P waves; fibrillatory baseline |
| Ventricular rhythm | Regular (irregular if block varies) | Irregularly irregular | Irregularly irregular |
| Driver | Structural heart disease, surgery, COPD | Lung disease, hypoxemia, theophylline | Atrial remodeling: age, hypertension, valve disease |
| Cardioversion | Works at low energy | Ineffective | Works |
| Anticoagulation | By CHA2DS2-VASc | Not for MAT itself | By CHA2DS2-VASc |
Premature atrial and ventricular beats
| Feature | PAC | PVC |
|---|---|---|
| ECG | Early, differently shaped P wave; narrow QRS | Early wide QRS with no preceding P wave |
| Pause | Usually less than compensatory (resets the sinus node) | Usually a full compensatory pause |
| Clinical weight | Benign in a normal heart; may herald AF | Benign in a normal heart; high burden can weaken the LV |
Triggers and workup. Caffeine, alcohol, nicotine, stimulants and decongestants, sleep loss, stress, low potassium or magnesium, and hyperthyroidism all provoke ectopy. Evaluate with an ECG, a Holter monitor to measure burden, potassium, magnesium, TSH, and an echocardiogram. In bigeminy, every other beat is a weak early beat, so the pulse may feel slow or "skipped" despite a normal electrical rate.
Structurally normal heart. Isolated PACs and PVCs are benign. Reassure, cut back caffeine, alcohol, and stimulants, and correct electrolytes. For bothersome palpitations use a β-blocker (or a non-dihydropyridine calcium channel blocker). Avoid class IC drugs after MI: they raised mortality in the CAST trial.
PVC-induced cardiomyopathy. Very frequent PVCs, above about 10–15% of all beats on Holter, can cause a reversible cardiomyopathy. Suspect it when the ejection fraction falls with no other cause after coronary disease, scar, and infiltration are excluded. Catheter ablation of the focus, often in the right ventricular outflow tract, is the most effective therapy, with β-blockers or amiodarone as alternatives, and the EF often normalizes. Flecainide is avoided when EF is reduced, and because the cardiomyopathy is reversible, it is not by itself an indication for an ICD.